# Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

> **NCT01820299** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 22 (actual)

## Conditions studied

- Solid Cancers

## Interventions

- **DRUG:** Grape Seed Extract
- **DRUG:** Vitamin D

## Key facts

- **NCT ID:** NCT01820299
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820299, "Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01820299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*